Skip to main content

Field Guide

Top Cardiology Journals

Journals for cardiovascular research, heart studies, and cardiology practice. This guide covers 5 journals with impact factors, acceptance rates, review timelines, and open access costs - everything you need to choose the right venue for your research.

5
Journals Covered
3
Elite / Top Tier
2
Strong Options
0
More Accessible

Journal Comparison Table

JournalTierImpact FactorAcceptance RateReview TimeOpen Access
European Heart JournalTop Tier45.3~10%~20 daysSee details
CirculationTop Tier41.3~7%17 days median to first decisionSee details
Journal of the American College of Cardiology
JACC
Top Tier21.7~5%14-21 days for initial decisionSee details
Circulation ResearchStrong Option16.5~10%21-35 days for initial decisionSee details
JAMA CardiologyStrong Option15.6~8%14-21 days to first decisionSee details

Found your target journal - now check if your manuscript is ready

Most desk rejections come down to scope and framing, not the science itself. Start with the Free Readiness Scan to check your manuscript against what cardiology editors actually look for before you commit to a submission.

Start with the Free Readiness Scan. Unlock the Full Review from $39, with local pricing shown before checkout. If you need deeper submission planning, choose the Submission-Ready Dossier.

Anthropic Privacy Partner. Your manuscript is never used to train any model.

Run my Free Readiness Scan →

Understanding Journal Tiers

Top Tier

Tier 1 (Circulation, JACC, European Heart Journal): The 'big three.' For practice-changing clinical trials, major cohort studies, or groundbreaking mechanistic insights. Circulation and JACC: 8-12 weeks to first decision, 85%+ desk rejection. European Heart Journal: similar selectivity.

Strong Option

Tier 2 (JAMA Cardiology, Circulation Research): JAMA Cardiology for clinical research that doesn't meet the big three bar. Circulation Research for basic/translational work - mechanism, not clinical trials. Both are excellent venues but not in the top tier.

Accessible

Tier 3: For cardiology-specific journals not listed above (e.g., JACC: Cardiovascular Interventions, European Journal of Heart Failure). These are solid for subspecialty work when the big journals aren't realistic.

Publishing in Cardiology

Cardiology publishing is dominated by three journals that form the core of the field: Circulation, JACC, and European Heart Journal. Understanding the subtle differences between these giants is crucial for manuscript placement. Circulation is the American Heart Association's flagship journal and the most-cited cardiovascular journal. It publishes across the full spectrum - from basic science to clinical trials. If your work impacts how cardiologists practice, Circulation wants it. JACC (Journal of the American College of Cardiology) is arguably the most influential cardiology journal in terms of clinical practice guidelines. JACC editors are particularly rigorous about clinical trial methodology. If your work doesn't meet CONSORT standards, don't bother submitting. European Heart Journal is the global counterpart to JACC, with slightly more European authorship and a broader scope that includes more translational work. It's considered equal in prestige to Circulation and JACC - the "big three" of cardiology. JAMA Cardiology, launched in 2016, has rapidly established itself as a major venue. It offers faster timelines than the traditional giants and is particularly strong on health services research and outcomes. Circulation Research focuses on basic and translational cardiovascular science - not clinical cardiology. If your work is about mechanisms of heart disease, not clinical trials, this is your venue.

Guidance by Career Stage

🎓 Graduate Students

Grad students face significant barriers in cardiology - the field is dominated by clinical data from large trials, which grad students rarely have. Your realistic path: Circulation Research for basic work, or build a publication record in less selective journals first. Don't aim for the big three without exceptional data and senior co-authorship.

🔬 Postdocs

Postdocs with clinical trial data should target JAMA Cardiology first - faster timeline, more accessible. With strong trial results and a PI with credentials at the big three, Circulation/JACC/EHJ become realistic. Postdocs with basic science should target Circulation Research.

👨‍🔬 Principal Investigators

PIs in cardiology benefit from the field's clinical focus. The big three are realistic targets if you have rigorous clinical data. Consider JACC for US-focused impact, European Heart Journal for global reach, Circulation for breadth. JAMA Cardiology is a strong choice for faster publication with solid impact.

⏱️ Review Timelines

Circulation: 8-12 weeks to first decision, typically 3-4 months from submission to acceptance for selected papers. JACC: 6-10 weeks initial review, very efficient. European Heart Journal: 8-12 weeks. JAMA Cardiology: 4-8 weeks, faster than the big three. Circulation Research: 6-10 weeks.

🔓 Open Access & Costs

All major cardiology journals are subscription-based. Circulation offers open access for ~$4,500. JACC offers open access for ~$5,000. European Heart Journal charges ~€4,000-5,000 for open access. JAMA Cardiology: $3,000 for open access. Circulation Research: ~$4,000.

Common Mistakes to Avoid

  • Submitting basic science to Circulation instead of Circulation Research
  • Not following CONSORT guidelines for clinical trial submissions to JACC
  • Not having an external statistical reviewer look at your clinical data before submission
  • Confusing Circulation (clinical) with Circulation Research (basic)

Frequently Asked Questions

Which cardiology journal has the highest impact factor?

Circulation leads at 38.6, followed by European Heart Journal (35.6) and JACC (21.7). However, JACC is arguably the most influential for US clinical practice - impact and influence don't always correlate in cardiology.

What's the difference between Circulation and Circulation Research?

Circulation publishes clinical cardiology - trials, outcomes, guidelines. Circulation Research publishes basic and translational cardiovascular science - mechanisms, models, physiology. They have different scopes and different audiences.

Can I submit a cohort study to Circulation Research?

No - Circulation Research specifically focuses on 'original research on the biology of the cardiovascular system.' Cohort studies with clinical outcomes belong in Circulation, JACC, or European Heart Journal.

More Guides in This Field

Circulation Research • Manuscript prep
Circulation Research Cover Letter: What Editors Actually Need to See
Circulation Research cover letters work when they make the mechanistic cardiovascular case quickly and avoid sounding like a generic cardiology pitch.
Circulation Research • Publishing guide
Circulation Research Formatting Requirements: The Submission Package Guide
Circulation Research formatting problems are usually mechanism-package problems: the abstract, figure order, supplement, and disclosure layer all have to support one mechanistic cardiovascular claim.
Circulation Research • Impact factor
Circulation Research Impact Factor 2026: 18, Q1, Rank 6/237
Circulation Research impact factor is 18 with a 5-year JIF of 23. See the rank, trend, and what that means before submission.
European Heart Journal • Acceptance rate
European Heart Journal Acceptance Rate: What Authors Can Use
European Heart Journal does not publish a strong official acceptance rate. The better submission question is whether the study is large-scale, clinically consequential, and positioned to influence ESC guidelines.
European Heart Journal • Publishing costs
European Heart Journal APC and Open Access: OUP Pricing, ESC Discounts, and Your Options
European Heart Journal APC starts with a free standard route, then an optional OUP OA charge shaped by article type, discounts, and agreements.
JACC • Journal assessment
Is JACC a Good Journal? A Practical Fit Verdict
A practical JACC fit verdict for authors deciding whether their study really belongs in the flagship cardiology journal rather than a specialty title.
JAMA Cardiology • Journal assessment
Is JAMA Cardiology a Good Journal? The JAMA Network's Cardiovascular Title
JAMA Cardiology JIF 15.2 is the JAMA Network's cardiovascular journal. Here's when it's the right target, how the JAMA transfer pipeline works, and how it compares to JACC, Circulation, and EHJ.
Journal • Submission guide
JACC CardioOncology Submission Guide
A practical JACC: CardioOncology submission guide for authors deciding whether the manuscript really changes the cardiovascular care conversation for patients with cancer.
JACC • Publishing guide
JACC Formatting Requirements: The Submission Package Guide
JACC formatting is really clinical-package formatting: title discipline, structured abstract, central illustration, perspectives, disclosures, and a manuscript that looks ready for a fast editorial read.
JAMA Cardiology • Manuscript prep
JAMA Cardiology Cover Letter: What Editors Actually Need to See
JAMA Cardiology cover letters work when they show a broad cardiology consequence quickly and avoid sounding like a prestige pitch for a narrower paper.
JAMA Cardiology • Publishing guide
JAMA Cardiology Formatting Requirements: The Submission Package Guide
JAMA Cardiology formatting is not mainly stylistic. It is a disciplined JAMA Network package: 3000-word research paper, structured abstract, Key Points, reporting checklist, data sharing, and clean display-item limits.
Journal • Desk rejection
How to Avoid Desk Rejection at JACC: CardioOncology (2026)
Avoid desk rejection at JACC: CardioOncology with a clearer cardio-oncology care consequence, stronger journal fit, and a more actionable first read.

Ready to submit? Check your manuscript first.

Start with the Free Readiness Scan to review your scope, significance framing, methods, and literature coverage against cardiology journal standards before you submit.

Start with the Free Readiness Scan. Unlock the Full Review from $39, with local pricing shown before checkout. If you need deeper submission planning, choose the Submission-Ready Dossier.

Anthropic Privacy Partner. Your manuscript is never used to train any model.

Run my Free Readiness Scan →